Skip to main content
Zhenqi Liu, MD, Endocrinology, Charlottesville, VA

Zhenqi Liu MD

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Thyroid


Professor of Medicine, Division of Endocrinology and Metabolism, University of Virginia School of Medicine

Join to view full profile
  • 415 Ray C Hunt DrSte 2100Charlottesville, VA 22903

  • Phone+1 434-924-1825

  • Fax+1 434-244-9456

Dr. Liu is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Zhenqi Liu is a board-certified endocrinologist based in Charlottesville, Virginia, recognized for his expertise in diagnosing and managing complex hormonal and metabolic disorders. His clinical practice focuses on diabetes, thyroid disease, and a wide range of endocrine conditions, with a patient-centered approach that integrates the latest advances in the field with individualized, evidence-based care.

    Dr. Liu completed his fellowship in Endocrinology, Diabetes, and Metabolism at the University of Virginia Medical Center, where he received advanced training in both clinical medicine and research. He earned his medical degree from Hunan Medical University and completed his residency in Internal Medicine at MedStar Health/Georgetown–Washington Hospital Center, building a strong foundation in the management of diverse acute and chronic conditions.

    With extensive clinical experience, Dr. Liu cares for patients with diabetes mellitus—including type 1, type 2, and complex cases requiring advanced insulin management—as well as thyroid disorders such as hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer. His expertise also extends to obesity and related metabolic conditions, lipid disorders, and osteoporosis, for which he provides comprehensive evaluation and long-term management aimed at reducing fracture risk and improving overall metabolic health.

    In addition to his clinical work, Dr. Liu has made significant contributions to endocrine and metabolic research. His publications span areas such as insulin delivery systems, the metabolic and physiological effects of exercise, GLP-1 receptor agonist (GLP-1RA) therapies, and vascular insulin sensitivity. His work has been widely cited in peer-reviewed literature, underscoring its impact on the field. He has also participated in multiple clinical trials investigating mechanisms of insulin resistance and evaluating the effects of exercise interventions and pharmacologic therapies on metabolic outcomes.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
  • MedStar Health/Georgetown-Washington Hospital Center
    MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1995 - 1998
  • Hunan Medical University
    Hunan Medical UniversityClass of 1983

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1998 - 2028
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Identification of a Distinct Phenotype of Elderly Latent Autoimmune Diabetes in Adults: LADA China Study 8  
    Zhenqi Liu, Xiangbing Wang, Diabetes/Metabolism Research and Reviews

Lectures

  • Identification of Autoimmune Type 1 Diabetes and Multiple Organ‐Specific Autoantibodies in Adult‐Onset Non‐Insulin Requiring Diabetes in China: A Population Based Mult... 
    Charlottesville, VA - 6/16/2014
  • Identification of Autoimmune Type 1 Diabetes and Multiple Organ‐Specific Autoantibodies in Adult‐Onset Non‐Insulin Requiring Diabetes in China: A Population Based Mult... 
    Charlottesville, VA - 6/14/2014
  • Identification of Autoimmune Type 1 Diabetes and Multiple Organ‐Specific Autoantibodies in Adult‐Onset Non‐Insulin Requiring Diabetes in China: A Population Based Mult... 
    Charlottesville, VA - 6/16/2014

Press Mentions

  • Older Americans Quit Weight-Loss Drugs in Droves
    Older Americans Quit Weight-Loss Drugs in DrovesDecember 21st, 2025
  • People with More Muscle Mass and Less Visceral Fat Have Younger Brains, Study Finds
    People with More Muscle Mass and Less Visceral Fat Have Younger Brains, Study FindsNovember 24th, 2025
  • Ozempic Users Be Aware: Fat Melts Away, but so Does Muscle
    Ozempic Users Be Aware: Fat Melts Away, but so Does MuscleAugust 7th, 2025

Grant Support

  • Impact of obesity on microvascular insulin action and cardiorespiratory fitness in Type 1 DiabetesUNIVERSITY OF VIRGINIA2026–2031
  • Role of Microvascular insulin resistance and cardiorespiratory fitness in diabetesUNIVERSITY OF COLORADO DENVER2021–2027
  • Research Training in Neuroendocrinology and MetabolismUNIVERSITY OF VIRGINIA1990–2027
  • Research Training in Neuroendocrinology and MetabolismUNIVERSITY OF VIRGINIA1990–2027
  • Effects of Exercise and GLP-1R Agonism on Muscle Microvascular Perfusion and Insulin ActionUNIVERSITY OF VIRGINIA2020–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: